FI874451A0 - Förfarande för framställning av som läkemedel användbara dihydropyridinderivat - Google Patents
Förfarande för framställning av som läkemedel användbara dihydropyridinderivatInfo
- Publication number
- FI874451A0 FI874451A0 FI874451A FI874451A FI874451A0 FI 874451 A0 FI874451 A0 FI 874451A0 FI 874451 A FI874451 A FI 874451A FI 874451 A FI874451 A FI 874451A FI 874451 A0 FI874451 A0 FI 874451A0
- Authority
- FI
- Finland
- Prior art keywords
- group
- alkyl
- substituent selected
- alkoxy
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24025486 | 1986-10-09 | ||
JP24025486 | 1986-10-09 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI874451A0 true FI874451A0 (sv) | 1987-10-09 |
FI874451A FI874451A (sv) | 1988-04-10 |
FI90543B FI90543B (sv) | 1993-11-15 |
FI90543C FI90543C (sv) | 1994-02-25 |
Family
ID=17056752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI874451A FI90543C (sv) | 1986-10-09 | 1987-10-09 | Förfarande för framställning av som läkemedel användbara dihydropyridinderivat |
Country Status (20)
Country | Link |
---|---|
US (1) | US4772596A (sv) |
EP (2) | EP0266922B1 (sv) |
JP (1) | JPS63253082A (sv) |
KR (1) | KR920004483B1 (sv) |
CN (1) | CN1017897B (sv) |
AT (2) | ATE146169T1 (sv) |
AU (1) | AU600038B2 (sv) |
CA (1) | CA1309098C (sv) |
DE (2) | DE3787346T2 (sv) |
DK (1) | DK170891B1 (sv) |
ES (2) | ES2059391T3 (sv) |
FI (1) | FI90543C (sv) |
GR (1) | GR3022301T3 (sv) |
HK (2) | HK1005727A1 (sv) |
HU (1) | HU199454B (sv) |
IE (1) | IE63111B1 (sv) |
NO (1) | NO170084C (sv) |
NZ (1) | NZ222106A (sv) |
RU (1) | RU1831476C (sv) |
ZA (1) | ZA877518B (sv) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2671349B1 (fr) * | 1991-01-09 | 1993-04-23 | Lafon Labor | Nouveaux derives de 1,4-dihydropyridine, leur procede de preparation et composition therapeutique les contenant. |
US5310917A (en) * | 1991-09-13 | 1994-05-10 | Merck & Co., Inc. | Process for the preparation of 4-substituted-1,4-dihydropydrines |
AU4688301A (en) * | 2000-04-11 | 2001-10-23 | Sankyo Co | Stabilized pharmaceutical compositions containing calcium channel blockers |
AU2001284413A1 (en) * | 2000-08-30 | 2002-03-13 | Sankyo Company Limited | Medicinal compositions for preventing or treating heart failure |
EP1577309A4 (en) * | 2002-12-24 | 2007-01-24 | Sankyo Co | OPTICALLY ACTIVE DIHYDROPYRIDINE DERIVATIVE |
JP4546726B2 (ja) * | 2002-12-24 | 2010-09-15 | 宇部興産株式会社 | 光学活性なジヒドロピリジン誘導体 |
NZ541454A (en) * | 2003-01-31 | 2008-04-30 | Daiichi Sankyo Co Ltd | Medicine for prevention of and treatment for arteriosclerosis and hypertension |
JP4629973B2 (ja) * | 2003-09-22 | 2011-02-09 | 第一三共株式会社 | 光学活性シクロプロピルアミン誘導体およびその製造方法 |
HUE025625T2 (en) * | 2003-12-12 | 2016-04-28 | Daiichi Sankyo Co Ltd | Intermediates for the preparation of optically active cyclopropylamine derivatives and a process for the preparation of intermediates |
US20100221327A1 (en) * | 2005-06-15 | 2010-09-02 | Elan Pharma International Limited | Nanoparticulate azelnidipine formulations |
TWI405580B (zh) * | 2005-06-27 | 2013-08-21 | Sankyo Co | 含有血管收縮素ii接受器拮抗劑及鈣通道阻斷劑之醫藥調配物 |
CN100352818C (zh) * | 2005-09-23 | 2007-12-05 | 四川科伦药业股份有限公司 | 一种改进的制备阿折地平的方法 |
TW200806648A (en) * | 2005-11-29 | 2008-02-01 | Sankyo Co | Acid addition salts of dihydropyridine derivatives |
TW200736245A (en) * | 2005-11-29 | 2007-10-01 | Sankyo Co | Acid addition salts of optically active dihydropyridine derivatives |
TWI399223B (zh) * | 2006-09-15 | 2013-06-21 | Daiichi Sankyo Co Ltd | 奧美沙坦酯及氨氯地平之固體劑型 |
JP2008290988A (ja) * | 2007-05-28 | 2008-12-04 | Ube Ind Ltd | 光学活性なジヒドロピリジン誘導体の酸付加塩を含有する医薬 |
JP2008290989A (ja) * | 2007-05-28 | 2008-12-04 | Ube Ind Ltd | ジヒドロピリジン誘導体の酸付加塩を含有する医薬 |
IT1391113B1 (it) * | 2008-09-30 | 2011-11-18 | Dipharma Francis Srl | Procedimento per la preparazione di azelnidipina cristallina |
JP5463051B2 (ja) * | 2009-02-17 | 2014-04-09 | 相模化成工業株式会社 | 1,4―ジヒドロピリジン誘導体の製造法 |
CN101863879B (zh) * | 2009-04-16 | 2012-12-19 | 四川科伦药物研究有限公司 | 一种α晶型阿折地平的制备方法 |
JP2011006379A (ja) * | 2009-05-26 | 2011-01-13 | Tokuyama Corp | {2−アミノ−1,4−ジヒドロ−6−メチル−4−(3−ニトロフェニル)−3,5−ピリジンジカルボン酸3−(1−ジフェニルメチルアゼチジン−3−イル)エステル5−イソプロピルエステル}(アゼルニジピン)の再結晶方法、アゼルニジピンのイソプロピルアルコール付加体、およびアゼルニジピンの製造方法 |
JP2011105649A (ja) * | 2009-11-18 | 2011-06-02 | Daito Kk | アゼルニジピンの結晶 |
JP5637710B2 (ja) * | 2010-03-24 | 2014-12-10 | 株式会社トクヤマ | {2−アミノ−1,4−ジヒドロ−6−メチル−4−(3−ニトロフェニル)−3,5−ピリジンジカルボン酸3−(1−ジフェニルメチルアゼチジン−3−イル)エステル5−イソプロピルエステル}の製造方法 |
JP2012020970A (ja) * | 2010-07-15 | 2012-02-02 | Tokuyama Corp | {2−アミノ−1,4−ジヒドロ−6−メチル−4−(3−ニトロフェニル)−3,5−ピリジンジカルボン酸3−(1−ジフェニルメチルアゼチジン−3−イル)エステル5−イソプロピルエステル}の製造方法 |
US9198902B2 (en) | 2011-04-29 | 2015-12-01 | Xuanzhu Pharma Co., Ltd. | 1,4-dihydropyridine-3,5-dicarboxylate derivatives and preparation and use thereof |
JP5917034B2 (ja) * | 2011-07-15 | 2016-05-11 | ニプロ株式会社 | カルシウムブロッカーを含有する固形医薬組成物 |
CA2846387C (en) | 2011-08-26 | 2016-02-09 | Wockhardt Limited | Methods for treating cardiovascular disorders |
CN102329259B (zh) * | 2011-10-21 | 2013-09-18 | 南京工业大学 | (1-二苯甲基-3-吖丁啶醇)氰基乙酸酯的制备方法 |
CN102382104A (zh) * | 2011-11-21 | 2012-03-21 | 山东新华制药股份有限公司 | α晶型阿折地平的制备方法 |
CN103319457B (zh) * | 2012-03-20 | 2016-01-27 | 北京晶润宏达医药科技有限公司 | 阿折地平γ晶型的制备方法 |
WO2017063307A1 (zh) * | 2015-10-13 | 2017-04-20 | 山东轩竹医药科技有限公司 | 1,4-二氢吡啶-3,5-二羧酸酯衍生物的制备方法及中间体 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1670827C3 (de) * | 1967-03-20 | 1974-10-24 | Bayer Ag, 5090 Leverkusen | 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin |
DE2003146A1 (de) * | 1970-01-24 | 1971-07-29 | Bayer Ag | Neue 1,4-Dihydropyridinderivate |
US3935223A (en) * | 1972-03-06 | 1976-01-27 | Bayer Aktiengesellschaft | 2-Amino-1,4-dihydropyridine derivatives |
GB1455502A (en) * | 1973-02-20 | 1976-11-10 | Yamanouchi Pharma Co Ltd | 1,4-dihydropyridine derivatives |
JPS55301A (en) * | 1978-02-14 | 1980-01-05 | Yamanouchi Pharmaceut Co Ltd | 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation |
JPS57171968A (en) * | 1981-04-17 | 1982-10-22 | Kyowa Hakko Kogyo Co Ltd | 1,4-dihydropyridine derivative |
JPS5970666A (ja) * | 1982-10-15 | 1984-04-21 | Kyowa Hakko Kogyo Co Ltd | 1,4−ジヒドロピリジン誘導体 |
DE3244178A1 (de) * | 1982-11-30 | 1984-05-30 | Bayer Ag, 5090 Leverkusen | 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
EP0125803A3 (en) * | 1983-04-27 | 1987-01-21 | FISONS plc | Pharmaceutically active dihydropyridines |
GB8314744D0 (en) * | 1983-05-27 | 1983-07-06 | Fujisawa Pharmaceutical Co | 2 6-disubstituted-1 4-dihydropyridine derivative |
US4603135A (en) * | 1983-10-17 | 1986-07-29 | Takeda Chemical Industries, Ltd. | Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates |
JPS6289662A (ja) * | 1985-06-14 | 1987-04-24 | Sankyo Co Ltd | 1,4−ジヒドロピリジン誘導体 |
-
1987
- 1987-10-05 US US07/105,388 patent/US4772596A/en not_active Expired - Lifetime
- 1987-10-06 KR KR1019870011142A patent/KR920004483B1/ko not_active IP Right Cessation
- 1987-10-07 ZA ZA877518A patent/ZA877518B/xx unknown
- 1987-10-08 RU SU874203529A patent/RU1831476C/ru active
- 1987-10-08 JP JP62254085A patent/JPS63253082A/ja active Granted
- 1987-10-09 HU HU874578A patent/HU199454B/hu unknown
- 1987-10-09 DK DK529987A patent/DK170891B1/da not_active IP Right Cessation
- 1987-10-09 ES ES87308976T patent/ES2059391T3/es not_active Expired - Lifetime
- 1987-10-09 CA CA000548953A patent/CA1309098C/en not_active Expired - Lifetime
- 1987-10-09 NO NO874219A patent/NO170084C/no unknown
- 1987-10-09 DE DE87308976T patent/DE3787346T2/de not_active Expired - Lifetime
- 1987-10-09 FI FI874451A patent/FI90543C/sv not_active IP Right Cessation
- 1987-10-09 ES ES92202251T patent/ES2097859T3/es not_active Expired - Lifetime
- 1987-10-09 CN CN87107150A patent/CN1017897B/zh not_active Expired
- 1987-10-09 AU AU79537/87A patent/AU600038B2/en not_active Expired
- 1987-10-09 NZ NZ222106A patent/NZ222106A/xx unknown
- 1987-10-09 AT AT92202251T patent/ATE146169T1/de not_active IP Right Cessation
- 1987-10-09 AT AT87308976T patent/ATE94162T1/de not_active IP Right Cessation
- 1987-10-09 EP EP87308976A patent/EP0266922B1/en not_active Expired - Lifetime
- 1987-10-09 EP EP92202251A patent/EP0529702B1/en not_active Expired - Lifetime
- 1987-10-09 DE DE3751978T patent/DE3751978T2/de not_active Expired - Lifetime
- 1987-10-09 IE IE270687A patent/IE63111B1/en not_active IP Right Cessation
-
1997
- 1997-01-16 GR GR970400061T patent/GR3022301T3/el unknown
-
1998
- 1998-06-03 HK HK98104825A patent/HK1005727A1/xx not_active IP Right Cessation
- 1998-06-03 HK HK98104824A patent/HK1005726A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI874451A (sv) | Förfarande för framställning av som läkemedel användbara dihydropyridinderivat | |
ATE89822T1 (de) | Durch benzhydryl n-substituierte heterocyclische derivate, ihre herstellung und ihre verwendung. | |
ATE126216T1 (de) | Pyrazolderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung. | |
ES2066000T3 (es) | Compuestos derivados de pirimidinediona, metodo de produccion de los mismos y agentes antirritmicos que los contienen. | |
ATE89559T1 (de) | Camptothecin-derivate und verfahren zu ihrer herstellung. | |
DK0385237T3 (da) | 2-(1-Piperazinyl)-4-phenylcycloalkanopyridinderivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat indeholdende dem | |
DE3873612D1 (de) | Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DK0490566T3 (da) | Fremstilling og anvendelse af N-iodpropargyloxycarbonylaminosyreestere og derivater som antimikrobielle midler | |
DE69324403D1 (de) | Herbizide 2,6-substituierte Pyridine | |
ATE75737T1 (de) | Indenothiazolderivate und verfahren zu ihrer herstellung. | |
KR870000299A (ko) | 1,4-디히드로피리딘 유도체의 제조방법 | |
DE69217717D1 (de) | Benzopyranderivate und Verfahren zu deren Herstellung | |
IL81933A (en) | Asymmetrical ester derivatives of 1,4-dihydro-2,6-dimethyl-4-phenyl-pyridine-3,5-dicarboxylic acid,their preparation and pharmaceutical compositions containing them | |
ATE118346T1 (de) | Verwendung von bis(4-hydroxyphenylthio)methan- derivaten zur behandlung von diabetes mellitus. | |
HUT55009A (en) | Process for producing imidazolyl and pyridyl derivatives of phenyl-substituted 1,4-dihydropyridines and pharmaceutical compositions comprising same | |
DK0410343T3 (da) | Anvendelse af bisphenolderivater til behandling af diabetes mellitus | |
KR910004632A (ko) | 신규한 1-옥사-2-옥소-8-아자스피로[4,5]데칸 유도체와 그들을 포함하는 약제학적 조성물 및 그 제조방법 | |
KR840001154A (ko) | 1,2-디티올-3-일리덴 암모늄 유도체의 제조방법 | |
FR2674246B1 (fr) | Nouveaux derives de l'acide alpha-methylene 5-thiazolacetique, leur procede de preparation et les intermediaires de ce procede, leur application a titre de fongicides et les compositions les renfermant. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Owner name: SANKYO COMPANY LIMITED Owner name: UBE INDUSTRIES LIMITED |
|
MA | Patent expired |